Tom Cruise’s ‘Digger’ could be one of Hollywood’s biggest flops ever, with a projected $245 million loss

Warner Bros.’ “Digger” opened to $8 million domestically and has grossed $35.3 million worldwide through its second weekend, against a reported break-even estimate of about $350 million; Variety projects a $245 million theatrical loss and roughly $50 million in final global grosses. Production costs rose from a reported $125 million budget to $160 million–$180 million, with about $100 million in marketing, while the studio says break-even is closer to $300 million. The film was Warner Bros.’ final release before Paramount Skydance completed its roughly $110 billion acquisition of Warner Bros. Discovery on Oct. 6.

Analysis

The investable signal is less the loss on one title than the governance test it creates for the newly combined company. A theatrical shortfall does not translate dollar-for-dollar into consolidated losses: streaming, licensing, and later-window receipts may recover value, while production and marketing costs are already committed. Verify the film’s actual studio share, residuals, and downstream licensing before treating the reported loss estimate as cash impact. Against a transaction of this scale, the title alone is unlikely to reset valuation; the more material risk is that it becomes evidence of weak greenlight controls and triggers impairments, slate cuts, or integration friction.

Over the next 1–3 months, watch management commentary on content spending, write-downs, and the combined slate. Over 6–18 months, tighter budget discipline could improve returns but also reduce original-film volume, leaving room for rivals to capture distinctive projects and talent. The bearish narrative may be overgeneralizing from an intentionally non-mainstream film whose economics depended on unusually strong word of mouth. The thesis weakens if downstream revenue materially offsets the theatrical miss or the company maintains content budgets without adverse guidance; it strengthens if further titles underperform and management signals broader impairments or spending cuts. No standalone short is justified by this title without evidence that the miss changes consolidated guidance or integration economics.

Key Decisions for Investors

• Do not trade WBD/PSKY solely on the reported box-office loss; first verify the film’s recognized impairment, studio net receipts, and any effect on consolidated guidance. The reported theatrical-loss estimate is not a measure of company cash loss.
• Set a 1–3 month alert for combined-company commentary on content write-downs, production-budget controls, and slate changes. Broader cuts or repeated impairments would support a bearish reassessment of the acquired studio assets; a single-title miss would not.
• For a 6–18 month relative-value watchlist, assess whether disciplined spending improves returns without reducing the studio’s ability to attract talent and distinctive projects. Consider relative exposure to competing content platforms only after evidence of slate reductions or talent displacement emerges.
• Falsification checks: material ancillary/licensing recovery, no impairment or guidance change, or subsequent releases demonstrating resilient demand would undercut the bearish read. Repeated costly underperformance or explicit content-budget reductions would strengthen it.